Main Menu

Our Work

United States ex rel. Donald R. Galmines v. Novartis Pharmaceuticals Corp.

In United States ex rel. Donald R. Galmines v. Novartis Pharmaceuticals Corp., served as a testifying expert on causation and damages on behalf of Novartis in connection with alleged FCA violations concerning alleged off-label promotion of Novartis’s Elidel®, a brand-name topical calcineurin inhibitor (TCI). Provided expert report.

Jump to Page